… background of two landmark randomized clinical trials (RCTs), … on day 8 of cycle 1 after the
first two doses of bortezomib (… Previously untreated MM patients with advanced, unresectable …

… Conclusion: We identified CAE safety signals for bortezomib and carfilzomib exposure …
, unlike clinical trials or observational studies where follow-ups of treated patients are made. …

… MM patients included in phase 3 randomized control trials with … to 54% of patients with
previously untreated symptomatic MM [… A systematic review and meta-analysis of 25 prospective …

… of this network meta-analysis of randomized controlled trials (… Preferred Reporting Items for
Systematic Reviews and Meta-… in DLBCL patients, while dacetuzumab or bortezomib added …

… This was contrary to results from a recent meta-analysis, 35 which … population not studied
previously in other clinical trials (… for previously untreated MM, including patients with poor-risk …

… Multiple randomized controlled trials (RCT) have shown that PD-… systematic review and
meta-analysis to investigate the impact of PD-L1 expression on the survival outcomes of patients …

… bortezomib-based induction and autologous stem cell transplantation in patients with previously
untreated multiple myeloma… of multiple myeloma: meta-analysis of trials with biological …

… or bortezomib is the standard of care in myeloma patients. … on a meta-analysis of different
phase III trials demonstrating an … the phase 3, randomised controlled trial. Lancet Haematol. …

… multiple myeloma worldwide (panel 1). Our suggestions serve to complement the findings
of clinical trials specific to multiple myeloma… from phase 3 randomised controlled trials), with …

… represented in the main randomized clinical trials (RCT), and … Patients with RRMM previously
treated with bortezomib (V) … or Rd doublets in a network meta-analysis (with a reduction in …